Posted by John Deo
The consensus price target for CRISPR Therapeutics AG (NASDAQ:CRSP) has been adjusted from $72.75 to $65, ref
Source: Two Blokes Trading
Posted by John Deo
ADI's consensus price target has been on an upward trend, indicating growing analyst optimism about the compa
Source: Two Blokes Trading
Posted by John Deo
Matador Resources Company's (NYSE:MTDR) consensus price target has risen from $77.87 to $84 over the past yea
Source: Two Blokes Trading
Posted by John Deo
Medical Properties Trust, Inc. (NYSE:MPW) is a real estate investment trust (REIT) that focuses on acquiring a
Source: Two Blokes Trading
Posted by John Deo
Cullen/Frost Bankers, Inc. (NYSE:CFR) has a Return on Invested Capital (ROIC) of 0.83%, significantly lower t
Source: Two Blokes Trading
Posted by John Deo
Palo Alto Networks (NASDAQ:PANW) is a leading cybersecurity company known for its innovative approach, levera
Source: Two Blokes Trading
Posted by John Deo
Intercontinental Hotels Group PLC (LSE:IHG) reported an EPS of $2.28, slightly below the estimated $2.29, but
Source: Two Blokes Trading
Posted by John Deo
Medtronic's EPS of $1.39 exceeded the Zacks Consensus Estimate, showcasing strong financial performance. The
Source: Two Blokes Trading
Posted by John Deo
Asian currencies extended losses on Tuesday as the U.S. dollar rebounded, fueled by fresh tariff concerns unde
Source: Two Blokes Trading
Posted by John Deo
The upcoming week holds several key market-moving events, including a crucial U.S.-Russia me
Source: Two Blokes Trading
Posted by John Deo
The Nifty 50 correction continues to unfold as Bank of America (BofA) predicts single-digit returns for 2025,
Source: Two Blokes Trading
Posted by John Deo
Gold prices continue their bullish momentum, with UBS revising its price target upward, projecting a potential
Source: Two Blokes Trading